YARROW BIOSCIENCE, INC. (YARW) Current Ratio
- Current ratio · latest quarter: Value 15.26×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 15.26× | Current assets / current liabilities. $23.53M ÷ $1.54M ≈ 15.26× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 23.53M USD | Assets, Current |
| Current obligations | 1.54M USD | Liabilities, Current |
| Cash and equivalents | 22.93M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 0.00 USD | Marketable Securities, Current |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | (m) | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $23.53M | $1.54M | $22.93M | $0.00 | (m) | (m) | (m) | (m) | 15.26× |
| 2026-03-31 | $25.79M | $1.24M | $24.63M | $297.00K | (m) | (m) | (m) | (m) | 20.86× |
| 2025-12-31 | $30.01M | $2.40M | $24.03M | $4.98M | (m) | (m) | (m) | (m) | 12.53× |
| 2025-06-30 | $44.34M | $5.84M | $22.05M | $17.60M | (m) | (m) | (m) | (m) | 7.60× |
| 2025-03-31 | $54.91M | $12.29M | $28.21M | $22.06M | (m) | (m) | (m) | (m) | 4.47× |
| 2024-12-31 | $64.44M | $14.82M | $19.93M | $41.59M | (m) | (m) | (m) | (m) | 4.35× |
| 2024-09-30 | $73.53M | $12.66M | $16.27M | $53.91M | (m) | (m) | (m) | (m) | 5.81× |
| 2024-06-30 | $83.78M | $11.75M | $29.61M | $48.49M | (m) | (m) | (m) | (m) | 7.13× |
| 2024-03-31 | $90.22M | $6.93M | $19.07M | $66.89M | (m) | (m) | (m) | (m) | 13.02× |
| 2023-12-31 | $95.96M | $7.54M | $30.62M | $62.63M | (m) | (m) | (m) | (m) | 12.73× |
| 2023-09-30 | $17.51M | $6.45M | $15.45M | (m) | $250.00K | (m) | (m) | (m) | 2.72× |
| 2023-06-30 | $22.96M | $6.37M | $20.63M | (m) | $234.00K | (m) | (m) | (m) | 3.60× |
| 2023-03-31 | $33.02M | $7.52M | $30.21M | (m) | $105.00K | (m) | (m) | (m) | 4.39× |
| 2022-12-31 | $38.27M | $9.35M | $30.91M | $0.00 | (m) | (m) | (m) | (m) | 4.10× |
| 2021-09-30 | $76.13M | $21.00M | $52.31M | $0.00 | $10.08M | $8.07M | (m) | $0.00 | 3.63× |
| 2021-06-30 | $128.43M | $57.62M | $103.41M | $0.00 | $10.87M | $8.28M | (m) | $33.38M | 2.23× |
| 2021-03-31 | $143.12M | $21.55M | $118.52M | $1.03M | $10.76M | $8.09M | (m) | (m) | 6.64× |
| 2020-12-31 | $87.26M | $21.77M | $57.56M | $1.03M | $15.82M | $7.40M | (m) | (m) | 4.01× |
| 2020-09-30 | $98.16M | $23.19M | $72.96M | $3.05M | $11.19M | $6.65M | (m) | (m) | 4.23× |
| 2020-06-30 | $119.29M | $24.23M | $96.51M | $2.61M | $6.41M | $5.80M | (m) | (m) | 4.92× |
| 2020-03-31 | $98.44M | $56.59M | $57.60M | $23.79M | $8.33M | $3.21M | (m) | (m) | 1.74× |
| 2019-12-31 | $76.41M | $29.33M | $43.76M | $16.25M | $135.00K | $1.36M | (m) | (m) | 2.61× |
| 2019-09-30 | $93.43M | $9.45M | $34.24M | (m) | (m) | (m) | $2.99M | (m) | 9.88× |
| 2019-06-30 | $113.13M | $11.91M | $65.06M | (m) | (m) | (m) | $4.70M | (m) | 9.50× |
| 2019-03-31 | $125.22M | $10.63M | $61.96M | (m) | (m) | (m) | $3.78M | (m) | 11.78× |
| 2018-12-31 | $139.50M | $9.54M | $49.51M | (m) | (m) | (m) | $3.29M | (m) | 14.62× |
| 2018-09-30 | $154.47M | $8.06M | $70.20M | (m) | (m) | (m) | $2.70M | (m) | 19.16× |
| 2018-06-30 | $156.16M | $8.65M | $73.58M | (m) | $93.00K | (m) | $5.09M | (m) | 18.06× |
| 2018-03-31 | $159.66M | $8.47M | $78.53M | (m) | $234.00K | (m) | $3.50M | (m) | 18.85× |
| 2017-12-31 | $63.86M | $7.82M | $10.21M | (m) | $786.00K | (m) | $2.46M | (m) | 8.17× |
| 2016-12-31 | $31.54M | $3.90M | $4.03M | (m) | $0.00 | (m) | $1.53M | (m) | 8.08× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |